KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biogen (BIIB) Net Income (2016 - 2026)

Biogen has reported Net Income over the past 18 years, most recently at $319.5 million for Q1 2026.

For Q1 2026, Net Income rose 32.85% year-over-year to $319.5 million; the TTM value through Mar 2026 reached $1.4 billion, down 7.26%, while the annual FY2025 figure was $1.3 billion, 20.79% down from the prior year.
Net Income for Q1 2026 was $319.5 million at Biogen, up from -$48.9 million in the prior quarter.
Over five years, Net Income peaked at $1.1 billion in Q3 2022 and troughed at -$68.3 million in Q3 2023.
A 5-year average of $433.2 million and a median of $388.5 million in 2024 define the central range for Net Income.
Biggest five-year swings in Net Income: surged 1538.48% in 2022 and later tumbled 118.34% in 2025.
Year by year, Net Income stood at $549.5 million in 2022, then plummeted by 54.7% to $248.9 million in 2023, then grew by 7.15% to $266.7 million in 2024, then tumbled by 118.34% to -$48.9 million in 2025, then skyrocketed by 753.37% to $319.5 million in 2026.
Business Quant data shows Net Income for BIIB at $319.5 million in Q1 2026, -$48.9 million in Q4 2025, and $466.5 million in Q3 2025.